Asset Details
Do you wish to reserve the book?
A computational neurodegenerative disease progression score: Method and results with the Alzheimer's disease neuroimaging initiative cohort
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
A computational neurodegenerative disease progression score: Method and results with the Alzheimer's disease neuroimaging initiative cohort
Do you wish to request the book?
A computational neurodegenerative disease progression score: Method and results with the Alzheimer's disease neuroimaging initiative cohort
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
A computational neurodegenerative disease progression score: Method and results with the Alzheimer's disease neuroimaging initiative cohort
2012
Overview
While neurodegenerative diseases are characterized by steady degeneration over relatively long timelines, it is widely believed that the early stages are the most promising for therapeutic intervention, before irreversible neuronal loss occurs. Developing a therapeutic response requires a precise measure of disease progression. However, since the early stages are for the most part asymptomatic, obtaining accurate measures of disease progression is difficult. Longitudinal databases of hundreds of subjects observed during several years with tens of validated biomarkers are becoming available, allowing the use of computational methods. We propose a widely applicable statistical methodology for creating a disease progression score (DPS), using multiple biomarkers, for subjects with a neurodegenerative disease. The proposed methodology was evaluated for Alzheimer's disease (AD) using the publicly available AD Neuroimaging Initiative (ADNI) database, yielding an Alzheimer's DPS or ADPS score for each subject and each time-point in the database. In addition, a common description of biomarker changes was produced allowing for an ordering of the biomarkers. The Rey Auditory Verbal Learning Test delayed recall was found to be the earliest biomarker to become abnormal. The group of biomarkers comprising the volume of the hippocampus and the protein concentration amyloid beta and Tau were next in the timeline, and these were followed by three cognitive biomarkers. The proposed methodology thus has potential to stage individuals according to their state of disease progression relative to a population and to deduce common behaviors of biomarkers in the disease itself.
[Display omitted]
► A computational neurodegenerative disease progression score (DPS) is proposed ► The DPS combines measurements from multiple biomarkers ► Validation with the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort ► An Alzheimer's DPS (ADPS) is computed for each subject and time-point in ADNI ► Evidence for a common Alzheimer's disease progression within ADNI subjects
Publisher
Elsevier Inc,Elsevier Limited
